financetom
Business
financetom
/
Business
/
--Science Applications International Maintains Quarterly Dividend at $0.37 per Share, Payable April 26 to Shareholders of Record on April 12
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Science Applications International Maintains Quarterly Dividend at $0.37 per Share, Payable April 26 to Shareholders of Record on April 12
Mar 15, 2024 7:14 AM

09:55 AM EDT, 03/15/2024 (MT Newswires) --

Price: 143.94, Change: +0.76, Percent Change: +0.53

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NextDecade CFO Brent Wahl resigns
NextDecade CFO Brent Wahl resigns
Oct 8, 2025
Oct 8 (Reuters) - LNG company NextDecade ( NEXT ) said on Wednesday that Chief Financial Officer Brent Wahl had resigned and that Mike Mott would replace him on an interim basis, effective October 20. (Reporting by Katha Kalia in Bengaluru; Editing by Anil D'Silva) ...
Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million
Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million
Oct 8, 2025
Wilmington, DE, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) , an innovation-driven medical technology growth company, today announced the sale of its Dr. Comfort diabetic shoe business to Promus Equity Partners, a multi-family asset management firm based in Chicago, for consideration of up to $60 million in cash, consisting of an upfront payment of $45...
Alibaba Forms Robotics and Embodied AI Team Inside Qwen
Alibaba Forms Robotics and Embodied AI Team Inside Qwen
Oct 8, 2025
08:10 AM EDT, 10/08/2025 (MT Newswires) -- Alibaba ( BABA ) has set up an in-house robotics and embodied AI group within its Qwen unit, company executive Justin Lin said Wednesday. The team will push Qwen's multimodal foundation models toward foundation agents that use tools and memory for long-horizon reasoning, Lin said. The goal is to bring these systems from...
CervoMed Says Neflamapimod Shows Effective in Treating Dementia with Lewy Bodies Without Alzheimer's Overlap
CervoMed Says Neflamapimod Shows Effective in Treating Dementia with Lewy Bodies Without Alzheimer's Overlap
Oct 8, 2025
08:09 AM EDT, 10/08/2025 (MT Newswires) -- CervoMed ( CRVO ) said Wednesday that new data from its mid-stage trial showed that its drug, neflamapimod, may be a potential treatment for dementia with Lewy bodies, particularly in patients without signs of Alzheimer's disease co-pathology. The company said the results are from the final analysis of the 48-week trial, which included...
Copyright 2023-2026 - www.financetom.com All Rights Reserved